Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Oberwart – page 2

77 clinical trials in Oberwart, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Oberwart at a glance
77
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

77 trials in Oberwart

Open in trial search

Asthma

Recruiting

GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:GB-0895
  • Sponsor:Generate Biomedicines Inc.

A study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Omnix Medical Ltd.

Study of human normal immunoglobulin and teclistamab for infection prevention in adults with multiple myeloma receiving B-cell maturation antigen therapy

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Teclistamab
  • Sponsor:Takeda Development Center Americas Inc.

Study of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Cemdisiran
  • Sponsor:Regeneron Pharmaceuticals Inc.

Study on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Human Plasma Gelsolin, Recombinant
  • Sponsor:Bioaegis Therapeutics Inc.

Study Comparing Pirtobrutinib and Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Loxo Oncology Inc.

Study on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Protein C
  • Sponsor:Takeda Development Center Americas Inc.

Dermatitis atopic

Not yet recruiting

Study of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:LY3454738
  • Sponsor:Eli Lilly & Co.

Colitis ulcerative+1

Not yet recruiting

Study of ABBV-701 and Risankizumab Combination vs Monotherapy in Adults with Moderately to Severely Active Crohn’s Disease or Ulcerative Colitis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Colitis ulcerative+1

Not yet recruiting

Study of risankizumab plus anti‑α4β7 integrin antibody versus each alone in adults with moderately to severely active Crohn’s disease or ulcerative colitis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Endocrine ophthalmopathy

Not yet recruiting

Study on the Effects of VRDN-003 for Patients with Active Thyroid Eye Disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-003
  • Sponsor:Viridian Therapeutics Inc.

Chronic kidney disease+3

Not yet recruiting

Study on Dapagliflozin for Patients with Chronic Kidney Disease or Kidney Failure Undergoing Hemodialysis

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Medical University Of Vienna

Other cities in Austria

The busiest research cities in the country

All 48 cities in Austria

Clinical research in Oberwart

What the registry says about research in the country

01 Neuropathic Pain Research

Innovative research focusing on diabetic polyneuropathy and its chronic pain manifestations, evaluating new therapeutic approaches for enhanced patient care and pain management.

  • Diabetic Neuropathy
  • Chronic Pain Management
  • Add-on Treatment Studies

Clinical trials aim to assess both efficacy and patient tolerability of novel therapeutic interventions.

02 Trauma-Related Neuropathy

Studies examining post-operative and traumatic peripheral neuropathy, investigating innovative treatment options for patients experiencing persistent pain conditions.

  • Post-operative Neuropathy
  • Trauma-induced Pain
  • Peripheral Nerve Conditions

Research focuses on developing effective pain management strategies for trauma-related neural complications.

03 Central Neuropathy Studies

Comprehensive research into central neuropathy of various origins, evaluating treatment responses and developing targeted therapeutic approaches.

  • Central Nervous System
  • Pain Management Protocols
  • Treatment Efficacy

Trials aim to advance understanding and treatment of complex central nervous system pain conditions.

04 Chronic Back Pain Research

Dedicated studies investigating treatments for chronic back pain, exploring new therapeutic options to improve patient outcomes and quality of life.

  • Back Pain Management
  • Long-term Pain Relief
  • Treatment Optimization

Research centered on developing effective interventions for persistent back pain conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.